DUBLIN--(BUSINESS WIRE)--The "Angina Pectoris: Global Drug Forecast and Market Analysis to 2028" report has been added to ResearchAndMarkets.com's offering. This report focuses on the following forms ...

A compound designed to prevent chest pains in heart patients has shown promising results in animal studies, say scientists. In the second issue of the British Journal of Pharmacology to be published ...

Angina pectoris, often shortened to angina, is chest pain or discomfort caused by reduced blood flow to the heart and most ...

A new drug ranolazine is a safe and effective treatment for chronic stable angina and adds to the treatment options for patients with this condition. The treatment is discussed in a New Drug Class ...

An angina drug called trimetazidine has been in the news lately connected to the 2022 Winter Olympics, but it's been on the radar of anti-doping authorities for years. Russian media reported that the ...

jumped 9% Friday following an announcement that regulators approved its oral spray for relieving and preventing angina due to coronary artery disease. "The Food and Drug Administration's approval of ...

A drug used in the clinical treatment of angina symptoms also has an anti-inflammatory effect and reduces atherosclerotic plaques in blood vessels - thereby reducing the risk of heart attack or stroke ...

LOS ANGELES, March 27 (Reuters) - An angina drug made by CV Therapeutics Inc. failed to prove effective as a treatment for acute coronary syndrome, but favorable safety data could broaden its use, ...